The thirteenth Growing old Analysis & Drug Discovery (ARDD) Assembly, the world’s largest convention devoted to longevity biotechnology, will happen from October 1-3, 2026, on the David Rubenstein Treehouse at Harvard College. Marking the high-profile launch of Boston Longevity Week, this landmark occasion is formally organized by Insilico Medication, which additionally anchors the convention as a Tier 1 sponsor alongside Eli Lilly.
As longevity science quickly transitions from theoretical ideas to multi-billion-dollar therapeutic pipelines, ARDD 2026 stands because the premier world nexus connecting primary science, medical analysis, large pharma, and institutional buyers. Transferring the convention to Boston-the world epicenter of biomedical innovation-reflects the sphere’s evolution into mainstream medication.
Constructing on the large momentum of earlier years-including ARDD 2025 in Copenhagen, the place management from Eli Lilly and Novo Nordisk mentioned the profound longevity potential of GLP-1 receptor agonists in Nature Biotechnology-the 2026 convention solidifies getting older analysis as a core pillar of healthcare. High-tier pharmaceutical firms at the moment are actively creating industrial applications focusing on fibrosis, immunology, CNS, cardiometabolic illnesses, anti-muscle losing, and mobile rejuvenation.
The great 2026 program options extremely specialised every day tracks designed to drive medical translation and trade development:
October 1: Scientific Improvement Day and the Longevity Medication Monitor
October 2: AI in Drug Discovery Monitor
October 3: Future Know-how Monitor
Along with the primary scientific program, the convention will host a number of high-profile, invite-only receptions to facilitate networking amongst world decision-makers. Confirmed audio system already embody govt leaders from 10 of the world’s high pharmaceutical firms.
The convention is steered by an elite panel of world chairs representing high educational and scientific establishments: Vadim Gladyshev and Jesse Poganik (Harvard Medical College); Alex Zhavoronkov (Insilico Medication); Morten Scheibye-Knudsen and Daniela Bakula (The College of Copenhagen); Evelyne Bischof (Sheba Longevity Middle); and Maximilian Unfried (Nationwide College of Singapore). Additional cementing the assembly’s affect on world well being economics, the McKinsey Well being Institute joins ARDD 2026 because the Sole Information Accomplice.
Reflecting its world scale, ARDD 2026 has secured backing from an array of distinguished biotechnology and monetary establishments. Becoming a member of Tier 1 companions Eli Lilly and Insilico Medication are Tier 3 sponsors AbbVie, BioAge, Human Longevity, Tally Well being, Maxwell Biosciences, Gordian, TruDiagnostic, and Cyclarity Therapeutics. Synaro Capital helps the occasion as a Tier 4 sponsor, alongside Tier 5 sponsors together with Morgan Stanley, Wholesome Longevity, Intrinsic Capability, and QuadraScope.
To safe early-bird pricing and obtain instant notification when the registration system goes dwell, potential attendees are inspired to hitch the precedence waitlist. Please go to the official registration portal at https://agingpharma.org/registration or study extra at agingpharma.org.
Sponsorship alternatives stay out there throughout a number of tiers, together with custom-made packages for trade companions trying to interface with decision-makers from enterprise capital, academia, and large pharma.
